Table 2 Treatment with anti-resorptive agents and intra-articular steroids injections during follow-up
Treatment group
Sequential monotherapy (n = 81)Step-up combination therapy (n = 84)Initial combination with prednisone (n = 89)Initial combination with infliximab (n = 88)
Bisphosphonate use, % (n = 342)98276
No. of months used during follow-up†9 (6–9)8 (3–9)9 (6–9)6 (5–11)
Calcium supplement, % (n = 342)21183921
No. of months used during follow-up†9 (6–12)9 (3–10)9 (9–12)9 (8–12)
Vitamin D supplement, % (n = 342)912238
No. of months used during follow-up†9 (6–9)9 (5–9)9 (7–9)9 (6–9)
Calcium and/or vitamin D, % (n = 342)26244321
HRT use, % (n = 342)14131617
No. of years used†10 (3–17)9 (2–15)5 (3–11)5 (1–10)
Intra-articular steroids injections (min. 1–max. 6), %2525914
  • HRT, hormone replacement therapy.

  • *Mean (standard deviation). †Median (interquartile range).